Literature DB >> 8239249

HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study.

E E Telzak1, M A Chiasson, P J Bevier, R L Stoneburner, K G Castro, H W Jaffe.   

Abstract

OBJECTIVE: To determine the relative risk for human immunodeficiency virus (HIV-1) seroconversion in patients with and without genital ulcers caused by chancroid, syphilis, and herpes.
DESIGN: A prospective cohort study.
SETTING: An inner-city, sexually transmitted disease clinic. PATIENTS: Patients seronegative for HIV-1 with and without genital ulcers who were followed for a minimum of 3 months.
INTERVENTIONS: Questionnaire to obtain data on demographics, sexual behavior, and illicit drug use; testing for HIV-1 at entry and at a minimum of 3 months after entry; medical examination for the presence or absence of genital ulcer disease.
RESULTS: Overall, 758 heterosexual men with no history of injection drug use completed the study; HIV-1 seroconversion occurred in 10 of 344 (2.9%; 95% CI, 1.4% to 5.3%) men with a genital ulcer and in 4 of 414 (1%; CI, 0.2% to 2.5%) without a genital ulcer (relative risk, 3.0; P = 0.05). In a multiple logistic regression analysis, those men with chancroid and a new sexually transmitted disease during follow-up each had about three times the risk for HIV-1 seroconversion (P < or = 0.04).
CONCLUSIONS: In this group of heterosexual men, chancroid and repeated acquisition of sexually transmitted diseases appeared to facilitate the sexual transmission of HIV-1.

Entities:  

Mesh:

Year:  1993        PMID: 8239249     DOI: 10.7326/0003-4819-119-12-199312150-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  40 in total

1.  Circumcision and STD in the United States: cross sectional and cohort analyses.

Authors:  R A Diseker; T A Peterman; M L Kamb; C Kent; J M Zenilman; J M Douglas; F Rhodes; M Iatesta
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

2.  Heterosexual HIV transmission and STD prevalence: predictions of a theoretical model.

Authors:  A M Renton; L Whitaker; M Riddlesdell
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

Review 3.  Interactions between HIV-1 and mucosal cells in the female reproductive tract.

Authors:  Ruizhong Shen; Holly E Richter; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-04-01       Impact factor: 3.886

4.  Molecular characterization of Haemophilus ducreyi isolates from different geographical locations.

Authors:  J Mbwana; I Bölin; E Lyamuya; F Mhalu; T Lagergård
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Haemophilus ducreyi is susceptible to protegrin.

Authors:  K Fortney; P A Totten; R I Lehrer; S M Spinola
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

6.  High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.

Authors:  S J Reynolds; A R Risbud; M E Shepherd; A M Rompalo; M V Ghate; S V Godbole; S N Joshi; A D Divekar; R R Gangakhedkar; R C Bollinger; S M Mehendale
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

7.  Characterization of the hemolytic activity of Haemophilus ducreyi.

Authors:  P A Totten; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Quality of Sexually Transmitted Infection Case Management Services in Gauteng Province, South Africa: An Evaluation of Health Providers' Knowledge, Attitudes, and Practices.

Authors:  David Cal Ham; Susan Hariri; Mary Kamb; Jennifer Mark; Ricky Ilunga; Sara Forhan; Mupatal Likibi; David A Lewis
Journal:  Sex Transm Dis       Date:  2016-01       Impact factor: 2.830

9.  Sexually transmitted infections and male circumcision: a systematic review and meta-analysis.

Authors:  Robert S Van Howe
Journal:  ISRN Urol       Date:  2013-04-16

10.  Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males.

Authors:  Stephanie L Sansom; Vimalanand S Prabhu; Angela B Hutchinson; Qian An; H Irene Hall; Ram K Shrestha; Arielle Lasry; Allan W Taylor
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.